Skip to content

Clinical trials

Phase 1 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Clear all

779 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200014
200111
20028
200312
200416
200521
200629
200726
200825
200927
201023
201126
201225
201322
201435
201527
201640
201728
201827
201937
202038
202142
202224
202336
202444
202537
202643

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed424
Terminated96
Recruiting93
Active, not recruiting62
Unknown status51
Withdrawn28
Not yet recruiting16
Suspended6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)45
Memorial Sloan Kettering Cancer Center28
Jonsson Comprehensive Cancer Center18
Janssen Research & Development, LLC17
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins17
M.D. Anderson Cancer Center16
AstraZeneca10
Mayo Clinic10
Novartis Pharmaceuticals10
Weill Medical College of Cornell University10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms779
Breast Neoplasms140
Ovarian Neoplasms87
Neoplasms83
Carcinoma, Non-Small-Cell Lung72
Pancreatic Neoplasms70
Colorectal Neoplasms62
Neoplasm Metastasis58
Lung Neoplasms54
Urinary Bladder Neoplasms52

Trials

Showing 1 to 25 of 779. Each trial links to its page on Pharma Observatory.

679 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.